602
Views
8
CrossRef citations to date
0
Altmetric
ORIGINAL RESEARCH

Antimicrobial Resistance Patterns, Sequence Types, Virulence and Carbapenemase Genes of Carbapenem-Resistant Klebsiella pneumoniae Clinical Isolates from a Tertiary Care Teaching Hospital in Zunyi, China

, , , , , , & ORCID Icon show all
Pages 637-649 | Received 23 Nov 2022, Accepted 10 Jan 2023, Published online: 29 Jan 2023
 

Abstract

Purpose

Carbapenem-resistant Klebsiella pneumoniae (CRKP) has seriously threatened public health worldwide. This study aimed to investigate the antimicrobial resistance patterns, sequence types (STs), virulence and carbapenemase genes of CRKP isolates from patients in Zunyi, China.

Methods

CRKP isolates were collected from the First People’s Hospital of Zunyi between January 2018 and December 2020. Antimicrobial susceptibility was determined using a VITEK®2 analyzer and confirmed using either the broth dilution method, Kirby–Bauer method, or E-test assays. Carbapenemase production was examined using a modified carbapenem inactivation method. STs of the studied isolates were determined by multilocus sequence typing, and the presence of carbapenemase and virulence genes was examined using polymerase chain reaction assays.

Results

In total, 94 CRKP isolates were collected. All studied isolates produced carbapenemase, and the most common carbapenemase gene was New Delhi metallo-β-lactamase (NDM; 72.3%), followed by Klebsiella pneumoniae carbapenemase (KPC; 24.5%), and Verona integron-encoded metallo-β-lactamase (VIM; 3.2%). Of the studied isolates, 74.3% exhibited multidrug-resistant (MDR) phenotype, and 25.7% were either pandrug-resistant (PDR) or extensively drug-resistant (XDR) phenotypes. The most prevalent sequence type was ST2407 (37.2%), followed by ST76 (21.3%) and ST11 (11.7%). The NDM gene was present in 97.1% of ST2407 isolates and 90.0% of ST76 isolates, whereas the KPC gene was present in 90.9% of ST11 isolates. The majority of the isolates carried wabG, uge, and fimH virulence genes, with prevalence rates of 94.7%, 92.6%, and 94.7%, respectively.

Conclusion

This study describes NDM-producing ST2407 and ST76, as well as KPC-producing ST11, as the major clonal types of CRKP isolates in Zunyi, China. All CRKP isolates were resistant to multiple types of antibiotics, and the majority of isolates carried carbapenemase and virulence genes. Clonal spread of NDM-producing CRKP ST2407 and ST76, and KPC-producing CRKP ST11 should be strictly monitored.

Abbreviations

CRKP, carbapenem-resistant Klebsiella pneumoniae; Kp, Klebsiella pneumoniae; KPC, Klebsiella pneumoniae carbapenemase; NDM, New Delhi metallo-β-lactamase; VIM, Verona integron-encoded metallo-β-lactamase; IMP, Imipenemase metallo-β-lactamase; OXA-48, Oxacillin hydrolyzing enzymes-48; mCIM, modified carbapenem inactivation method; eCIM, EDTA-carbapenem inactivation method; MLST, multilocus sequence typing. MDR, multidrug-resistant; XDR, extensively drug-resistant; PDR, pandrug-resistant; CZO, cefazolin; CXM, cefuroxime; CRO, ceftriaxone; CAZ, ceftazidime; FEP, cefepime; ATM, aztreonam; CTT, cefotetan; IPM, imipenem; MEM, meropenem; ETP, ertapenem; SAM, ampicillin/sulbactam; TZP, piperacillin/tazobactam; SCF, cefoperazone/sulbactam; CZA, ceftazidime/avibactam; CIP, ciprofloxacin; LEV, levofloxacin; CN, gentamicin; TOB, tobramycin; AK, amikacin; TGC, tigecycline; SXT, trimethoprim/sulfamethoxazole.

Ethics Statement

This study was approved by the Ethics Committee of the First People’s Hospital of Zunyi (No. 2020-068). The need for written informed consent was waived because the samples were routinely collected and patients’ anonymous information was provided by the microbiology hospital laboratory. This study completely followed the principles outlined in the Declaration of Helsinki.

Disclosure

The authors report no conflicts of interest in this work.

Additional information

Funding

This project was supported by the Guizhou High-level (BAI) Innovative Talents Project (QIANKehe Platform & Talents-GCC[2022]042-1); National Natural Science Foundation of China (No.81760475); Innovation Group Project provided by the Guizhou Provincial Department of Education (QianJiaoheKYzi [2021]019); Key Discipline Project of Clinical Laboratory Diagnostics funded by Guizhou Provincial Health Commission (QianWeijianhan[2021]160); Key Discipline Project of Clinical Laboratory Diagnostics funded by Zunyi Municipal Health Bureau (2022-1444); and Zunyi United Science and Technology Fund Project (Zunyi Kehe HZzi [2019]147, [2019]173 & [2022] 97).